JENNIFER HUNSAKER: Open Payments
NPI 1578937926 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 18 payments from 12 companies in 2025. Trend: 2023 $1,111 · 2024 $619 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 1 | $100 |
| Novartis Pharmaceuticals Corporation | 3 | $90 |
| Janssen Biotech, Inc. | 1 | $76 |
| GENZYME CORPORATION | 1 | $69 |
| Galderma Laboratories, L.P. | 1 | $64 |
| Almirall LLC | 2 | $61 |
| ABBVIE INC. | 2 | $45 |
| PFIZER INC. | 2 | $37 |
| Medline Industries LP | 1 | $33 |
| Organon LLC | 2 | $27 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, Rhapsido, SKYRIZI, CIBINQO, Klisyri, Seysara.
Industry payments across NY — which companies pay providers there.
